Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ROOPA INDUSTRIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ROOPA INDUSTRIES   TEVA PHARMA
EQUITY SHARE DATA
    ROOPA INDUSTRIES
Mar-23
TEVA PHARMA
Dec-13
ROOPA INDUSTRIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs933,477-   
Low Rs243,020-   
Sales per share (Unadj.) Rs96.81,995.2-  
Earnings per share (Unadj.) Rs1.7124.6-  
Cash flow per share (Unadj.) Rs2.8285.9-  
Dividends per share (Unadj.) Rs0109.11-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs17.72,216.3-  
Shares outstanding (eoy) m7.87848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.61.6 37.0%   
Avg P/E ratio x34.026.1 130.4%  
P/CF ratio (eoy) x20.511.4 180.2%  
Price / Book Value ratio x3.31.5 224.4%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m4592,754,567 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m320-   
Avg. sales/employee Rs Th037,645.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,351.7-  
INCOME DATA
Net Sales Rs m7621,691,953 0.0%  
Other income Rs m70-   
Total revenues Rs m7681,691,953 0.0%   
Gross profit Rs m39463,342 0.0%  
Depreciation Rs m9136,762 0.0%   
Interest Rs m1833,233 0.1%   
Profit before tax Rs m18293,347 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,566 -0.0%   
Tax Rs m5-3,581 -0.1%   
Profit after tax Rs m13105,695 0.0%  
Gross profit margin %5.127.4 18.6%  
Effective tax rate %25.3-1.2 -2,072.8%   
Net profit margin %1.86.2 28.4%  
BALANCE SHEET DATA
Current assets Rs m4211,142,739 0.0%   
Current liabilities Rs m396996,565 0.0%   
Net working cap to sales %3.38.6 38.2%  
Current ratio x1.11.1 92.7%  
Inventory Days Days1791 19.0%  
Debtors Days Days33996 353.6%  
Net fixed assets Rs m145552,629 0.0%   
Share capital Rs m794,165 1.9%   
"Free" reserves Rs m610-   
Net worth Rs m1391,879,439 0.0%   
Long term debt Rs m17865,133 0.0%   
Total assets Rs m5653,866,655 0.0%  
Interest coverage x2.09.8 20.1%   
Debt to equity ratio x0.10.5 26.1%  
Sales to assets ratio x1.30.4 307.8%   
Return on assets %5.63.6 157.2%  
Return on equity %9.75.6 172.1%  
Return on capital %23.44.9 473.9%  
Exports to sales %00-   
Imports to sales %0.50-   
Net fx Rs m-30-   
CASH FLOW
From Operations Rs m89269,610 0.0%  
From Investments Rs m-10-95,534 0.0%  
From Financial Activity Rs m-75-323,415 0.0%  
Net Cashflow Rs m5-149,339 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.29 Rs / USD

Compare ROOPA INDUSTRIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ROOPA INDUSTRIES With: VILIN BIO MED  SHREE GANESH REMEDIES   MERCURY LAB.  SUN PHARMA  ALBERT DAVID  



Today's Market

Gift Nifty Down 65 Points | Axis Bank Q4 Results | Why Telecom Stocks are Falling | Top Buzzing Stocks Today Gift Nifty Down 65 Points | Axis Bank Q4 Results | Why Telecom Stocks are Falling | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended the higher.